Related references
Note: Only part of the references are listed.Vagal influences in rheumatoid arthritis
S. E. Rasmussen et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2018)
Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's Disease
Brian G. Feagan et al.
GASTROENTEROLOGY (2018)
Clinical factors are associated with vitamin D levels in IBD patients: A retrospective analysis
Holger Schaeffler et al.
JOURNAL OF DIGESTIVE DISEASES (2018)
Review article: the gut microbiome in inflammatory bowel diseaseavenues for microbial management
J. McIlroy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis
P. Kump et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis
Stefanos Bonovas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial
Susy S. Hota et al.
CLINICAL INFECTIOUS DISEASES (2017)
Next generation of small molecules in inflammatory bowel disease
Pablo Olivera et al.
GUT (2017)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Mechanisms of inflammation-driven bacterial dysbiosis in the gut
M. Y. Zeng et al.
MUCOSAL IMMUNOLOGY (2017)
Mucosal and systemic immune modulation by Trichuris trichiura in a self-infected individual
A. Dige et al.
PARASITE IMMUNOLOGY (2017)
Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population
Svein Oskar Frigstad et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Faecal microbiota transplantation: establishment of a clinical application framework
Simon M. D. Jorgensen et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
PREDIAGNOSTIC SERUM VITAMIN D LEVELS AND RISK OF INFLAMMATORY BOWEL DISEASE: A PAN-EUROPEAN, NESTED CASE-CONTROL STUDY
Jorrit Opstelten et al.
GASTROENTEROLOGY (2017)
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection
Stephan J. Ott et al.
GASTROENTEROLOGY (2017)
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Gilaad G. Kaplan et al.
GASTROENTEROLOGY (2017)
Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease
Allan B. Dietz et al.
GASTROENTEROLOGY (2017)
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases
James D. Lewis et al.
GASTROENTEROLOGY (2017)
European consensus conference on faecal microbiota transplantation in clinical practice
Giovanni Cammarota et al.
GUT (2017)
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panes et al.
GUT (2017)
Immune responses and parasitological observations induced during probiotic treatment with medicinal Trichuris suis ova in a healthy volunteer
Andrew R. Williams et al.
IMMUNOLOGY LETTERS (2017)
Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease
H. Matthew Cohn et al.
INFLAMMATORY BOWEL DISEASES (2017)
An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease
Matthew C. Choy et al.
INFLAMMATORY BOWEL DISEASES (2017)
The α4β1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo
Sebastian Zundler et al.
INFLAMMATORY BOWEL DISEASES (2017)
Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases
Sebastian Zundler et al.
INFLAMMATORY BOWEL DISEASES (2017)
Effect of Oral Capsule-vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection A Randomized Clinical Trial
Dina Kao et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Marcus Harbord et al.
JOURNAL OF CROHNS & COLITIS (2017)
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Sudarshan Paramsothy et al.
JOURNAL OF CROHNS & COLITIS (2017)
F-calprotectin and Blood Markers Correlate to Quality of Life in Pediatric Inflammatory Bowel Disease
Katrine Carlsen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Severine Vermeire et al.
LANCET (2017)
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
Sudarshan Paramsothy et al.
LANCET (2017)
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
Brian G. Feagan et al.
LANCET (2017)
Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy
Julian Panes et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Cong Dai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clarifying Stem-Cell Therapy's Benefits and Risks
Peter W. Marks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
Karen Dubois-Camacho et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Vitamin D increases programmed death receptor-1 expression in Crohn's disease
Mia Bendix et al.
ONCOTARGET (2017)
Optimizing pharmacologic management of inflammatory bowel disease
Shannon Chang et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Marcel Vetter et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
Changes in microbial ecology after fecal microbiota transplantation for recurrent C-difficile infection affected by underlying inflammatory bowel disease
Sahil Khanna et al.
MICROBIOME (2017)
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
Paul W. O'Toole et al.
NATURE MICROBIOLOGY (2017)
Review article: the human intestinal virome in health and disease
S. R. Carding et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease
Alireza Meighani et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population
Samantha Zullow et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study
Christopher Staley et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor-α medications among patients with inflammatory bowel diseases
R. W. Winter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Single-Center Experience
Samantha M. Chin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Inflammatory Bowel Diseases (IBD) immunopathogenesis: A comprehensive review of inflammatory molecules
Jae Hyon Park et al.
AUTOIMMUNITY REVIEWS (2017)
Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy
Z. D. Jiang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection
Samuel P. Costello et al.
CLINICAL INFECTIOUS DISEASES (2016)
Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy ininflammatory bowel disease
W. Moon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study
Toufi C. A. Kabbani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection
Colleen R. Kelly et al.
ANNALS OF INTERNAL MEDICINE (2016)
Curcumin for Inflammatory Bowel Disease: A Caution
Peter R. Holt
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Alexander Khoruts et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Avoidance of Fiber Is Associated With Greater Risk of Crohn's Disease Flare in a 6-Month Period
Carol S. Brotherton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study
Christian L. Hvas et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
Safety profile of methotrexate in inflammatory bowel disease
Tommaso Gabbani et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
Franck Carbonnel et al.
GASTROENTEROLOGY (2016)
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection A Randomized Clinical Trial
Christine H. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Sacral nerve stimulation enhances early intestinal mucosal repair following mucosal injury in a pig model
Jeremy Bregeon et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
Julian Panes et al.
LANCET (2016)
Understanding the mechanisms of faecal microbiota transplantation
Alexander Khoruts et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers
Philip M. Brown et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study
B. Bonaz et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Vitamin D status in relation to Crohn's disease: Meta-analysis of observational studies
Mehdi Sadeghian et al.
NUTRITION (2016)
Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
Frieda A. Koopman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis
Michelle Prosberg et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
The impact of genetic factors on response to glucocorticoids therapy in IBD
Marcin Gabryel et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Reduced numbers of mucosal DRint macrophages and increased numbers of CD103+ dendritic cells during anti-TNF-α treatment in patients with Crohn's disease
Anders Dige et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Methotrexate in Crohn's disease: a new face for an old drug?
Monica Cesarini et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut
Audrey Riviere et al.
FRONTIERS IN MICROBIOLOGY (2016)
What Are Adults With Inflammatory Bowel Disease (IBD) Eating? A Closer Look at the Dietary Habits of a Population-Based Canadian IBD Cohort
Kathy Vagianos et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2016)
Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease
S. K. Hourigan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection
G. Cammarota et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Intestinal, Antigen-Presenting Cells Key Regulators of Immune Homeostasis and Inflammation
Kyle L. Flannigan et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease
M. Bendix et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial
Alon Lang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
Paul Moayyedi et al.
GASTROENTEROLOGY (2015)
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
Noortje G. Rossen et al.
GASTROENTEROLOGY (2015)
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
Niels Vande Casteele et al.
GASTROENTEROLOGY (2015)
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
Colleen R. Kelly et al.
GASTROENTEROLOGY (2015)
Safety and Efficacy of AJM300, an Oral Antagonist of α4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis
Naoki Yoshimura et al.
GASTROENTEROLOGY (2015)
Diet in the Pathogenesis and Treatment of Inflammatory Bowel Diseases
Dale Lee et al.
GASTROENTEROLOGY (2015)
The Active Form of Vitamin D Transcriptionally Represses Smad7 Signaling and Activates Extracellular Signal-regulated Kinase (ERK) to Inhibit the Differentiation of a Inflammatory T Helper Cell Subset and Suppress Experimental Autoimmune Encephalomyelitis
Ravikanth Nanduri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Improvement of Refractory Ulcerative Proctitis With Sacral Nerve Stimulation
Jeremy Bregeon et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
Clinical Trials in Ulcerative Colitis: A Historical Perspective
Pieter Hindryckx et al.
JOURNAL OF CROHNS & COLITIS (2015)
Dietary management of IBD-insights and advice
Emma P. Halmos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease
Giovanni Monteleone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nutraceutical Supplements for Inflammatory Bowel Disease
Alyssa M. Parian et al.
NUTRITION IN CLINICAL PRACTICE (2015)
5-Aminosalicylic acid, a specific drug for ulcerative colitis
Oyvind Hauso et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study
Nynne Nyboe Andersen et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study
Nynne Nyboe Andersen et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study
Tara Raftery et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2015)
Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function
Louisa E. Jeffery et al.
PLOS ONE (2015)
The innate immune system and inflammatory bowel disease
Julie M. Davies et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
The Impact of Diet and Lifestyle on Gut Microbiota and Human Health
Michael A. Conlon et al.
NUTRIENTS (2015)
Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial
Casper Steenholdt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
First Multicenter Study of Modified Release Phosphatidylcholine LT-02 in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses
Max Karner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection
Alexa R. Weingarden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Update on Janus Kinase Antagonists in Inflammatory Bowel Disease
Brigid S. Boland et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2014)
Fiber in the Treatment and Maintenance of Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials
Linda Wedlake et al.
INFLAMMATORY BOWEL DISEASES (2014)
Vitamin D Levels in Adults with Crohn's Disease Are Responsive to Disease Activity and Treatment
Maggie Ham et al.
INFLAMMATORY BOWEL DISEASES (2014)
Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease
Wei Wang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
A tale of two diseases: The history of inflammatory bowel disease
Daniel J. Mulder et al.
JOURNAL OF CROHNS & COLITIS (2014)
Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis
Ruben J. Colman et al.
JOURNAL OF CROHNS & COLITIS (2014)
Smoking in inflammatory bowel disease: Impact on disease course and insights into the aetiology of its effect
Gareth C. Parkes et al.
JOURNAL OF CROHNS & COLITIS (2014)
Pretreatment 25-Hydroxyvitamin D Levels and Durability of Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Diseases
Zachary A. Zator et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2014)
The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?
Giada De Palma et al.
JOURNAL OF PHYSIOLOGY-LONDON (2014)
Vitamin D improves inflammatory bowel disease outcomes: Basic science and clinical review
Krista M. Reich et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Immunopathology of inflammatory bowel disease
Kori L. Wallace et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn's disease patients
Lars E. Bartels et al.
INFLAMMOPHARMACOLOGY (2014)
A tale of two diseases: The history of inflammatory bowel disease
Daniel J. Mulder et al.
JOURNAL OF CROHNS & COLITIS (2014)
Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease
W. J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study
Tine Jess et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Fecal microbiome transplantation for recurrent Clostridium difficile infection: Report on a case series
Timothy A. Rubin et al.
ANAEROBE (2013)
Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease
C. Liu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Transient Flare of Ulcerative Colitis After Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Lauren M. De Leon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Risks of Inflammatory Bowel Disease Treatment with Glucocorticosteroids and Aminosalicylates
Ivanka Curkovic et al.
DIGESTIVE DISEASES (2013)
Antimicrobial peptides and gut microbiota in homeostasis and pathology
Maureen J. Ostaff et al.
EMBO MOLECULAR MEDICINE (2013)
Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update
Vera Kandror Denmark et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
New therapeutic avenues in ulcerative colitis: thinking out of the box
Joana Torres et al.
GUT (2013)
Active Crohn's disease is associated with low vitamin D levels
Søren Peter Jørgensen et al.
Journal of Crohns & Colitis (2013)
How glucocorticoid receptors modulate the activity of other transcription factors: A scope beyond tethering
Dariusz Ratman et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease
Lars E. Bartels et al.
INFLAMMOPHARMACOLOGY (2013)
Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease
C. Steenholdt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection
Matthew J. Hamilton et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection
Lawrence J. Brandt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Probiotics in Transition
Fergus Shanahan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection
Eero Mattila et al.
GASTROENTEROLOGY (2012)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro
Anne Christine W. Vos et al.
INFLAMMATORY BOWEL DISEASES (2012)
Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins
Ean-jeong Seo et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines, and Chemokine Receptors in Patients With Inflammatory Bowel Disease Before and After Infliximab Treatment
Ingrid Arijs et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis
Patricia Lepage et al.
GASTROENTEROLOGY (2011)
Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages
Raja Atreya et al.
GASTROENTEROLOGY (2011)
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch et al.
GUT (2011)
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives
Marie Joossens et al.
GUT (2011)
Importance of Disrupted Intestinal Barrier in Inflammatory Bowel Diseases
Sa'ad Y. Salim et al.
INFLAMMATORY BOWEL DISEASES (2011)
Therapy with anti-TNF alpha Antibody Enhances Number and Function of Foxp(3+) Regulatory T Cells in Inflammatory Bowel Diseases
Gilles Boschetti et al.
INFLAMMATORY BOWEL DISEASES (2011)
Vitamin D Deficiency in Patients With Inflammatory Bowel Disease: Association With Disease Activity and Quality of Life
Alex Ulitsky et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2011)
1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
Sneha Joshi et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
The microbiome-gut-brain axis: from bowel to behavior
J. F. Cryan et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells
Anders Dige et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study
S. P. Jorgensen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Discrete changes in circulating regulatory T cells during infliximab treatment of Crohn's disease
Christian Lodberg Hvas et al.
AUTOIMMUNITY (2010)
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
R. DUCHMANN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary With Inflammatory Bowel Disease Phenotypes
Ben P. Willing et al.
GASTROENTEROLOGY (2010)
Peripheral Regulatory T Cells and Serum Transforming Growth Factor-β: Relationship with Clinical Response to Infliximab in Crohn's Disease
Antonio Di Sabatino et al.
INFLAMMATORY BOWEL DISEASES (2010)
Reciprocal Changes of Foxp3 Expression in Blood and Intestinal Mucosa in IBD Patients Responding to Infliximab
Zhe Li et al.
INFLAMMATORY BOWEL DISEASES (2010)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Andre Franke et al.
NATURE GENETICS (2010)
Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease
D. C. Baumgart et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1
Wendy W. J. Unger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
W. Kruis et al.
GUT (2009)
Transforming growth factor β signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures
A. Di Sabatino et al.
GUT (2009)
Low Counts of Faecalibacterium prausnitzii in Colitis Microbiota
H. Sokol et al.
INFLAMMATORY BOWEL DISEASES (2009)
Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population-based cohort followed for ten years
May-Bente Bengtson et al.
JOURNAL OF CROHNS & COLITIS (2009)
The long journey of salicylates in ulcerative colitis: The past and the future
Renzo Caprilli et al.
JOURNAL OF CROHNS & COLITIS (2009)
Probiotic E-coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans
M. Moendel et al.
MUCOSAL IMMUNOLOGY (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Association Between Water Supply and Inflammatory Bowel Disease Based on a 1990-1993 Cohort Study in Southeastern Norway
Geir Aamodt et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Tumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease
Mark A. Ainsworth et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2
M. Schlee et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Infectious gastroenteritis and risk of developing inflammatory bowel disease
Chad K. Porter et al.
GASTROENTEROLOGY (2008)
Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients
Geoffrey C. Nguyen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study
Martina E. Spehlmann et al.
INFLAMMATORY BOWEL DISEASES (2008)
Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes
Hiroki Fujita et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission
Luzia Valentini et al.
NUTRITION (2008)
Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease
B. Szebeni et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease
Masayuki Saruta et al.
CLINICAL IMMUNOLOGY (2007)
Functional modulation of crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies
Antonio Di Sabatino et al.
GASTROENTEROLOGY (2007)
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
Jochen Hampe et al.
NATURE GENETICS (2007)
Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease
S. Zeissig et al.
GUT (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Thiopurine treatment in inflammatory bowel disease - Clinical pharmacology and implication of pharmacogenetically guided dosing
Alexander Teml et al.
CLINICAL PHARMACOKINETICS (2007)
Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-β1-mediated suppression of colitis
Monica Boirivant et al.
GASTROENTEROLOGY (2006)
Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial
Hiroyuki Hanai et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Immunomodulating potential of supplementation with probiotics:: a dose-response study in healthy young adults
Hanne Risager Christensen et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4
Kimberly E. Beck et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: Their mechanisms of action and role in the treatment of IBD
JM van Dieren et al.
INFLAMMATORY BOWEL DISEASES (2006)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence
P. Desreumaux et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Curcumin, an atoxic antioxidant and natural NF kappa B, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: A shield against acute and chronic diseases
Stig Bengmark
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2006)
Curcumin therapy in inflammatory bowel disease: A pilot study
PR Holt et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Brief report - Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
G Van Assche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Genetics of Crohn disease, an archetypal inflammatory barrier disease
S Schreiber et al.
NATURE REVIEWS GENETICS (2005)
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ
C Rousseaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Trichuris suis therapy for active ulcerative colitis:: A randomized controlled trial
RW Summers et al.
GASTROENTEROLOGY (2005)
Selective inhibition of inflammatory gene expression in activated T lymphocytes: A mechanism of immune suppression by thiopurines
CW Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-α
H Mitoma et al.
GASTROENTEROLOGY (2005)
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance
JH Niess et al.
SCIENCE (2005)
Trichuris suis therapy in Crohn's disease
RW Summers et al.
GUT (2005)
Systematic review of sacral nerve stimulation for faecal incontinence and constipation
MED Jarrett et al.
BRITISH JOURNAL OF SURGERY (2004)
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis et al.
GUT (2004)
Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis
B Sheil et al.
GUT (2004)
Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease
JMH Van Den Brande et al.
GASTROENTEROLOGY (2003)
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
P Seksik et al.
GUT (2003)
Natalizumab for active Crohn's disease.
S Ghosh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A controlled trial of natalizumab for relapsing multiple sclerosis.
DH Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease
T ten Hove et al.
GUT (2002)
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
WJ Sandborn et al.
GASTROENTEROLOGY (2001)
Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway
A Lügering et al.
GASTROENTEROLOGY (2001)
Methotrexate suppresses NF-κB activation through inhibition of IκBα phosphorylation and degradation
S Majumdar et al.
JOURNAL OF IMMUNOLOGY (2001)
Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling
HG Pálmer et al.
JOURNAL OF CELL BIOLOGY (2001)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2000)
Share Paper
